Statin therapy, myopathy and exercise - A case report

Research output: Contribution to journalArticle

15 Citations (Scopus)
2 Downloads (Pure)

Abstract

In a bid to reduce the morbidity and mortality associated with coronary artery disease, statin therapy has become a cornerstone treatment for patients with dyslipideamia. Statins, or HMG-CoA reductase inhibitors, are effective in blocking hepatic synthesis of cholesterol and are generally regarded as safe. Although rare, severe adverse side effects such as rhabdomyolysis have been reported, however, the more common complaint from patients is that related to myopathy.
Original languageEnglish
Pages (from-to)40-41
Number of pages2
JournalLipids in Health and Disease
Volume11
DOIs
Publication statusPublished - 2012
Externally publishedYes

Fingerprint Dive into the research topics of 'Statin therapy, myopathy and exercise - A case report'. Together they form a unique fingerprint.

  • Cite this